FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: Nvidia's Huang Says US-China Meetings Were "Excellent"

By

Jensen Huang, Nvidia's chief executive officer, said the meetings between the U.S. and China "went excellent," according to a report on RTHK on Thursday.

In a last-minute decision, Huang joined U.S. President Donald Trump's delegates to Beijing, which included Tesla's Elon Musk and Apple's Tim Cook, the report said.

Huang also told state media CCTV he hoped the meeting between Trump and Chinese President Xi Jinping would be able to boost bilateral ties, Reuters reported on the same day.

Nvidia is currently unable to deliver its H200 chips to China, the report said.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Related Articles

Asia

Hansoh Pharma Gets China Nod for Trial of Tumor Drug

Hansoh Pharmaceutical's (HKG:3692) obtained clinical trial approval for its HS-10541 tablets from China's National Medical Products Administration, according to a Wednesday Hong Kong bourse filing.Shares of the pharma firm were down over 1% in Thursday afternoon trading.The trial will study the drug for the treatment of patients with KRAS G12C-mutated advanced solid tumors.

$HKG:3692
Asia

Kehua Bio-Engineering's Unit Gets Registration Certificate for Metapneumovirus Nucleic Acid Kit

Shanghai Kehua Bio-Engineering's (SHE:002022) unit, Suzhou Tianlong Biotechnology, received a medical device registration certificate from China's National Medical Products Administration for a swab kit for metapneumovirus nucleic acid, according to a Shenzhen bourse filing on Thursday.The certificate for the human metapneumovirus nucleic acid detection kit is valid until May 10, 2031.The Chinese in vitro diagnostics company's shares fell 2% during the afternoon trade.

$SHE:002022
Asia

CTBC Financial Books NT$5.4 Billion Profit in April

CTBC Financial (TPE:2891) booked a consolidated net profit of NT$5.40 billion for April, with pre-tax income of NT$6.58 billion, or according to a Thursday Taiwan Exchange filing.For the first four months of 2026, the group recorded an attribuatble net profit of NT$28.5 billion, or NT$1.46 per share.Meanwhile, cumulativewhile pre-tax income came in at NT$34.9 billion, the filing said.

$TPE:2891